![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Astellas Receives FDA Approval for Use of Prograf
Astellas Receives FDA Approval for Use of Prograf
May 28, 2009
The Food and Drug Administration (FDA) has granted Astellas Pharma US, Inc. approval for the use of Prograf (tacrolimus) in conjunction with mycophenolate mofetil for the prevention of organ rejection in kidney transplant recipients.
RedOrbit
RedOrbit
Upcoming Events
-
21Oct